Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines White Paper Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines Danielle Pillsbury2021年2月3日
BaseCase Interactive for Medical Affairs Brochure BaseCase Interactive for Medical Affairs Jim Gallagher2021年1月28日
Getting Real with RWE Article Getting Real with RWE By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…Certara2020年11月20日
Galderma Achieves FDA Approval of AKLIEF® (trifarotene) Case Study ガルデルマ社、AKLIEF®(トリファロテン)のFDA承認を取得 In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…Certara2020年11月9日
The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal White Paper The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal Jim Gallagher2020年10月28日
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU On-Demand Webinar SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU In this webinar, our experts provided an overview of the SNDS and the key working…Jim Gallagher2020年10月20日
New Pinnacle 21 Community Validation Engine: FDA (1907.2) Announcement New Pinnacle 21 Community Validation Engine: FDA (1907.2) In August 2020, we released our new Pinnacle 21 validation engine “FDA (1907.2)” for preparing…Certara2020年9月13日
Exploring Common CDISC ADaM Dataset Conformance Findings On-Demand Webinar Exploring Common CDISC ADaM Dataset Conformance Findings What you need to know when validating your CDISC ADAM datasets During the regulatory review…Danielle Pillsbury2020年9月3日
Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research Case Study Arvinas、ディスカバリーリサーチのスピードと効率性を高めるためにサターラの D360 を採用 In February 2020, we announced that Certara’s discovery research relationship with Arvinas had expanded to…Certara2020年8月21日